Evaluation of educational needs in patients with diabetes mellitus in respect of medication use in Austria
- 424 Downloads
Background Effective control of diabetes mellitus type 1 (DM1) and type 2 (DM2) can reduce the development and progression of diabetic complications. Therefore, patient education should be considered as an integral part of diabetes management. Objective The aim of the study was to assess DM patients’ perception of knowledge for their medication and attitude towards self-management and pharmacist’s role. Setting The study was conducted at the diabetes out-patient clinic at the Vienna General Hospital (AKH), Division of Endocrinology and Metabolism, Department of Internal Medicine III, Austria. Method The study was a cross sectional survey using patient data from a validated patient questionnaire and medical records. Medical records were evaluated by applying a medication assessment tool. Main outcome measure To assess the quality of diabetes self management the following outcome measures are considered: HbA1c levels, pre- and post-prandial blood glucose levels, prevention of acute episodes of hypo- and hyperglycaemia, reduction of macrovascular risk factors, short term quality of life, adverse effects and treatment tolerance. Results The present study comprised 225 patients with DM1 and 201 patients with DM2, respectively. In comparison to DM2 patients, cardio- and cerebrovascular diseases were diagnosed very rarely in patients with DM1. The risk for these diseases was higher in patients with other factors of the metabolic syndrome, in addition. Overall, 118 of these patients participated in the questionnaire. The level of positive response on diabetes self-care and knowledge with respect to medication for the prevention of diabetes complications, glycaemic control, and treatment goals in diabetes was 81.8 %. The comparison of patients’ perceptions of diabetes self-care and knowledge showed differences among subgroups. Higher perceived knowledge and self-care apparently was associated with DM1. Additional findings of this study indicate that patients do not expect community pharmacists to be integrated in a multidisciplinary diabetes care team. Conclusion Although the level of positive response was found to be high there is still a minority of patients whose level of comprehension appears to be insufficient. Intense pharmaceutical care including patients’ education within a multidisciplinary team could contribute to improvements in those patients.
KeywordsAustria Diabetes care Disease management Endocrine disorders Metabolic syndrome Patient education Primary care
Conflicts of interest
- 1.http://www.idf.org/. Accessed 01 Feb 2012.
- 3.Walker R, Whittlesea C. Clinical pharmacy and therapeutics. 4th Edition, Edinburgh, New York: Churchill Livingstone; 2007. ISBN 9780443102851.Google Scholar
- 4.National Institute for Clinical Excellence. (NICE Clinical Guideline 87) Type 2 diabetes. The management of type 2 diabetes. London: NICE; 2009. Accessed 1 Feb 2012.Google Scholar
- 6.Deakin T, McShane CE, Cade JE, Williams RDRR. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;2: CD003417.Google Scholar
- 10.Österreichische Diabetes Gesellschaft. Leitlinien der Österreichischen Diabetes Gesellschaft 2007; http://www.oedg.org/leitlinien.html. Accessed 01 Feb 2012.
- 11.American Diabetes Association. Standards of medical care in diabetes—2009. Diabetes Care. 2009;32:1514–22.Google Scholar
- 14.National Institute for Health and Clinical Excellence. (NICE Technology Appraisal 60) Guidance on the use of patient-education models for diabetes. London: NICE; 2003. Accessed 2009.Google Scholar
- 15.Scottish Intercollegiate Guidelines Network (SIGN). Clinical guidelines–numerical list. http://www.sign.ac.uk/guidelines/published/numlist.html. Accessed 01 Feb 2012.
- 19.SurveyGizmo©. Boulder, CO 80301 USA, http://www.surveygizmo.com/ .Accessed 2009.
- 20.QuickCalcs Online Calculator for Scientists. La Jolla, CA 92037, USA; http://www.graphpad.com/. Accessed 2009.
- 21.McAnaw J, Hudson S, McGlynn S. Development of an evidence-based medication assessment tool to demonstrate the quality of drug therapy use in patients with heart failure. Int J Pharm Pract. 2003;11:R17.Google Scholar
- 34.Austrian Pharmaceutical Chamber. 10 minutes for your health. http://www.apotheker.or.at/ Accessed 10 Feb 2012.